Advertisement

Table of Contents

July 01, 1983; Volume 24,Issue 1

You have access
Presynaptic antagonist-postsynaptic agonist at muscarinic cholinergic synapses. N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
O Nordström, P Alberts, A Westlind, A Undén and T Bartfai

Molecular Pharmacology July 1983, 24 (1) 1-5;
You have access
The interaction of dihydropyridine calcium channel blockers with calmodulin and calmodulin inhibitors.
S A Thayer and A S Fairhurst

Molecular Pharmacology July 1983, 24 (1) 6-9;
You have access
Molecular size of the canine and human brain D2 dopamine receptor as determined by radiation inactivation.
L Lilly, C M Fraser, C Y Jung, P Seeman and J C Venter

Molecular Pharmacology July 1983, 24 (1) 10-14;
You have access
Heterogeneity of binding sites on cardiac muscarinic receptors induced by the neuromuscular blocking agents gallamine and pancuronium.
J Dunlap and J H Brown

Molecular Pharmacology July 1983, 24 (1) 15-22;
You have access
Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus.
J C Meunier, Y Kouakou, A Puget and C Moisand

Molecular Pharmacology July 1983, 24 (1) 23-29;
You have access
The interaction between full and partial inhibitors acting on a single enzyme. A theoretical analysis.
P Palatini

Molecular Pharmacology July 1983, 24 (1) 30-41;
You have access
Forskolin does not activate sperm adenylate cyclase.
L R Forte, D B Bylund and W L Zahler

Molecular Pharmacology July 1983, 24 (1) 42-47;
You have access
Pharmacological characterization of the acetylcholine transport system in purified Torpedo electric organ synaptic vesicles.
D C Anderson, S C King and S M Parsons

Molecular Pharmacology July 1983, 24 (1) 48-54;
You have access
Inhibition of [3H]acetylcholine active transport by tetraphenylborate and other anions.
D C Anderson, S C King and S M Parsons

Molecular Pharmacology July 1983, 24 (1) 55-59;
You have access
Use of a monoclonal antibody for comparative studies of monoamine oxidase B in mitochondrial extracts of human brain and peripheral tissues.
R M Denney, R R Fritz, N T Patel, S G Widen and C W Abell

Molecular Pharmacology July 1983, 24 (1) 60-68;
You have access
Hepatic estrogen responsiveness. Possible mechanisms for sexual dimorphism.
C Thompson and G W Lucier

Molecular Pharmacology July 1983, 24 (1) 69-76;
You have access
Growth inhibition and metallothionein induction in cadmium-resistant cells by essential and non-essential metals.
R M Evans, S R Patierno, D S Wang, O Cantoni and M Costa

Molecular Pharmacology July 1983, 24 (1) 77-83;
You have access
Correlations of DNA strand breaks and their repair with cell survival following acute exposure to mercury(II) and X-rays.
O Cantoni and M Costa

Molecular Pharmacology July 1983, 24 (1) 84-89;
You have access
Preferential inhibition of 5-trifluoromethyl-2'-deoxyuridine phosphorylation by 5'-amino-5'-deoxythymidine in uninfected versus herpes simplex virus-infected cells.
P H Fischer, D G Murphy and R Kawahara

Molecular Pharmacology July 1983, 24 (1) 90-96;
You have access
The effects of the antitumor protein auromomycin on HeLa S3 nuclei. Release of soluble chromatin.
F Rauscher, G Mueller and T Beerman

Molecular Pharmacology July 1983, 24 (1) 97-102;
You have access
Biosynthesis of tetrahydrobiopterin in the presence of dihydrofolate reductase inhibitors.
D S Duch, C L Lee, M P Edelstein and C A Nichol

Molecular Pharmacology July 1983, 24 (1) 103-108;
You have access
Incorporation of 5-Aza-2'-deoxycytidine-5'-triphosphate into DNA. Interactions with mammalian DNA polymerase alpha and DNA methylase.
J Bouchard and R L Momparler

Molecular Pharmacology July 1983, 24 (1) 109-114;
You have access
Regioselectivity and stereoselectivity in the metabolism of trans-1,2-dihydroxy-1,2-dihydrobenz[a]anthracene by rat liver microsomes.
K P Vyas, P J van Bladeren, D R Thakker, H Yagi, J M Sayer, W Levin and D M Jerina

Molecular Pharmacology July 1983, 24 (1) 115-123;
You have access
Effect of nitrous oxide and methionine treatments on hepatic S-adenosylmethionine and methylation reactions in the rat.
A B Makar and T R Tephly

Molecular Pharmacology July 1983, 24 (1) 124-128;
You have access
Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo.
M Murray, C F Wilkinson, C Marcus and C E Dubé

Molecular Pharmacology July 1983, 24 (1) 129-136;
You have access
Betamethasone-mediated activation of biphenyl 2-hydroxylation in rat liver microsomes. Studies on possible mechanisms.
M S Miller, M T Huang, A M Jeffrey and A H Conney

Molecular Pharmacology July 1983, 24 (1) 137-145;
You have access
A high-spin form of cytochrome P-450 highly purified from polychlorinated biphenyl-treated rats. Catalytic characterization and immunochemical quantitation in liver microsomes.
T Kamataki, K Maeda, Y Yamazoe, N Matsuda, K Ishii and R Kato

Molecular Pharmacology July 1983, 24 (1) 146-155;
You have access
The relationship between increases in the hepatic content of cytochrome P-450, form 5, and in the metabolism of aromatic amines to mutagenic products following treatment of rabbits with phenobarbital.
I G Robertson, C Serabjit-Singh, J E Croft and R M Philpot

Molecular Pharmacology July 1983, 24 (1) 156-162;
You have access
An alpha1-adrenergic receptor-mediated phosphatidylinositol effect in canine cerebral microvessels.
R J Zeleznikar, E E Quist and L R Drewes

Molecular Pharmacology July 1983, 24 (1) 163-167;